Literature DB >> 12473401

Transient movement disorders and multiple sclerosis.

Alireza Minagar1, William A Sheremata, William J Weiner.   

Abstract

Movement disorders associated with multiple sclerosis (MS) are uncommon, except for tremor. We report two patients with relapsing-remitting MS, who developed either dystonia or chorea during clinical exacerbation of their MS. The movement disorders resolved during treatment with adrenocorticotropin hormone (ACTH). Acute exacerbations of MS may be associated with transient movement disorders, which are responsive to ACTH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473401     DOI: 10.1016/s1353-8020(02)00009-3

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Acute hemichorea as unusual first multiple sclerosis presentation.

Authors:  Giada Giovannini; Francesco Cavallieri; Stefano Meletti; Annalisa Chiari; Jessica Mandrioli; Diana Ferraro; Franco Valzania
Journal:  Neurol Clin Pract       Date:  2017-02

Review 2.  The thalamus and multiple sclerosis: modern views on pathologic, imaging, and clinical aspects.

Authors:  Alireza Minagar; Michael H Barnett; Ralph H B Benedict; Daniel Pelletier; Istvan Pirko; Mohamad Ali Sahraian; Elliott Frohman; Robert Zivadinov
Journal:  Neurology       Date:  2013-01-08       Impact factor: 9.910

Review 3.  Movement Disorders in Multiple Sclerosis: An Update.

Authors:  Ritwik Ghosh; Dipayan Roy; Souvik Dubey; Shambaditya Das; Julián Benito-León
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2022-05-04

4.  Kinesigenic paroxysmal hemidyskinesia as the initial presentation of multiple sclerosis.

Authors:  Yara Dadalti Fragoso; Mauro Gomes Araujo; Nilton Luiz Branco
Journal:  MedGenMed       Date:  2006-10-04

5.  Effect of acetazolamide for long-lasting paroxysmal dystonia in a patient with multiple sclerosis: a case report and review of literature.

Authors:  Pei-Chun Hsieh; Shu-Min Chen; Yao-Hong Guo; Ta-Shen Kuan; Wei-Jang Yen; Wen-Chen Chang; Yu-Ching Lin
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-04       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.